Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze FDMT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate FDMT investment potential.

What is FDMT stock price today?

Get real-time FDMT stock price, historical data, and price charts on Financhill. Track FDMT performance with our advanced analysis tools.

Is FDMT a good investment?

Evaluate FDMT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy FDMT stock?

To buy FDMT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of FDMT?

View detailed market capitalization data and company valuation metrics for FDMT on our comprehensive analysis page.

What is the P/E ratio of FDMT?

Use our fundamental analysis tools to view FDMT P/E ratio and compare valuation metrics with industry peers.

What are FDMT earnings?

View FDMT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

4D Molecular Therapeutics, Inc. Stock Predictions

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

FDMT
4D Molecular Therapeutics, Inc.

Last Price:

$10.70

Seasonality Move:

3.13%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

4D Molecular Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, 4D Molecular Therapeutics, Inc. has on average historically fallen by 10.9% based on the past 4 years of stock performance.
4D Molecular Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Is 4D Molecular Therapeutics, Inc. Stock Undervalued?

The current 4D Molecular Therapeutics, Inc. [FDMT] share price is $10.70. The Score for FDMT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will 4D Molecular Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, 4D Molecular Therapeutics, Inc. has on average historically fallen by 10.9% based on the past 4 years of stock performance.

4D Molecular Therapeutics, Inc. Stock Rating

Sell

4D Molecular Therapeutics, Inc. (FDMT) is a Sell

Is 4D Molecular Therapeutics, Inc. overpriced?

4D Molecular Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

4D Molecular Therapeutics, Inc. Stock Price History

Is FDMT stock going to rise?

The current trend is moderately bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

4dmoleculartherapeutics.com

52-Week Data

52-Week High:

12.34

52-Week Low:

2.24

Prediction Charts

Market Cap:

611.3M

Price in USD:

10.70

Volume:

485.7K

Beta:

2.99

Technical Analysis

SMA50:

10.32

SMA100:

8.26

SMA200:

6.00

52-Wk Change:

56.89%

Stock Predictions

Is 4D Molecular Therapeutics, Inc. stock public?

Yes, 4D Molecular Therapeutics, Inc. is a publicly traded company.
What is the 4D Molecular Therapeutics, Inc. stock quote today?

The 4D Molecular Therapeutics, Inc. stock price is 10.70 USD today.
How to buy 4D Molecular Therapeutics, Inc. stock online?

You can buy 4D Molecular Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	10.75	10.95	11.43	10.46
Nov-18	10.81	10.09	10.86	10.04
Nov-19	10.11	10.80	11.00	10.09
Nov-20	11.00	10.34	11.30	10.29
Nov-21	10.30	10.84	11.03	10.15
Nov-24	10.86	10.89	11.18	10.71
Nov-25	10.96	10.68	11.12	10.54
Nov-26	10.73	10.99	11.00	10.41
Nov-28	11.12	11.66	11.89	10.87
Dec-1	11.40	10.51	11.60	10.48
Dec-2	10.50	10.13	10.50	9.92
Dec-3	10.19	10.70	10.77	10.19
Dec-4	10.68	11.19	11.40	10.54
Dec-5	11.30	10.70	11.50	10.67

4D Molecular Therapeutics, Inc. Earnings

4D Molecular Therapeutics, Inc. Earnings Report: Per Share 4D Molecular Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

4D Molecular Therapeutics, Inc. Forecast Revenue Growth

4D Molecular Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for 4D Molecular Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.22 per share.

* 4D Molecular Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.